Difference between revisions of "Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia"
Jump to navigation
Jump to search
| Line 3: | Line 3: | ||
==General== | ==General== | ||
*Rare. | *Rare. | ||
Clinical:<ref name=pmid26112453>{{Cite journal | last1 = Chauhan | first1 = A. | last2 = Ramirez | first2 = RA. | title = Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) and the Role of Somatostatin analogs: A Case Series. | journal = Lung | volume = | issue = | pages = | month = Jun | year = 2015 | doi = 10.1007/s00408-015-9754-2 | PMID = 26112453 }}</ref> | |||
*Typical patient in 60s. | |||
*Cough. | |||
Treatment: | |||
*Somatostatin analogs<ref name=pmid26112453/> - improves cough. | |||
==Gross== | ==Gross== | ||
Revision as of 13:22, 25 September 2015
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia, abbreviated DIPNECH, is an uncommon lung pathology that is considered pre-neoplastic by the WHO.[1]
General
- Rare.
Clinical:[2]
- Typical patient in 60s.
- Cough.
Treatment:
- Somatostatin analogs[2] - improves cough.
Gross
- Multiple small pulmonary nodules.[1]
DDx:
Microscopic
See also
References
- ↑ 1.0 1.1 Wirtschafter, E.; Walts, AE.; Liu, ST.; Marchevsky, AM. (Jun 2015). "Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia of the Lung (DIPNECH): Current Best Evidence.". Lung. doi:10.1007/s00408-015-9755-1. PMID 26104490.
- ↑ 2.0 2.1 Chauhan, A.; Ramirez, RA. (Jun 2015). "Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) and the Role of Somatostatin analogs: A Case Series.". Lung. doi:10.1007/s00408-015-9754-2. PMID 26112453.